Therapeutic effect of an immunosupp-ressive agent, mizoribine in patients with the progression of renal failure in diabetic nephropathy
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 09 May 2017
At a glance
- Drugs Mizoribine (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 01 Apr 2009 New trial record.